Production processClosed Production

Products 121 to 130 of 174

Neossance Squalane by Aprinnova
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: Australia + Canada + China + Europe + Japan + Korea + Mexico + New Zealand + Philippines + Russia + USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Finished Product
Biotech components: Gene Editing
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Government + Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 1,650,980 USD
Funding types: Venture Capital
Industry: Food & Agriculture + Security
Market status: Under Development
Organization type(s): Private Company
Product categories: Design + Food + Threat detection
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Platform
Nootkatone by Isobionics
Biotech components: Plant
Business models: B2B
Country of production: Netherlands
Country of distribution: Netherlands
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Additive
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:52 (6 years ago)
Known funding amount: 1,900,000 USD
Funding types: Venture Capital
Industry: Health
Market status: On the market
Organization type(s): Private Company
Product categories: Personal Care (Ingested)
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Phyzyme XP Phytase by DuPont + Danisco
Biotech components: Bacteria
Business models: B2B
Country of production: USA + Denmark
Country of distribution: UK
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Feed
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
Pomecin by Evolva
Biotech components: Plant
Business models: B2B
Country of production: Switzerland
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/02 15:44 (6 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Plant
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input
Probiotic Strains by Unibome + Peer to Peer Probiotics
Biotech components: Probiotic
Business models: B2B
Country of production: France
Country of distribution: France
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Additive
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Probiotic
Business models: B2B
Country of production: USA
Country of distribution: North America + Africa + Europe + Asia
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/02 06:17 (6 years ago)
Known funding amount: 8,946 USD
Funding types: Crowdfunding
Industry: Health
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Probiotic
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Public Funding + Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Project Cyborg by Autodesk
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Science
Market status: Under Development
Organization type(s): Public Company
Product categories: Design
Production process: Closed Production
Source: SynBio Database
Trading symbol: ADSK (NASDAQ)
Value chain stage: Platform